| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.014 | 0.9 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.9 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | 0.022 | 0.9 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |